Literature DB >> 15188841

Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.

Usha Stiefel1, Nicole J Pultz, Marion S Helfand, Curtis J Donskey.   

Abstract

BACKGROUND: Antibiotic-associated disruption of the indigenous intestinal microflora may persist beyond the treatment period. Although piperacillin/tazobactam inhibits the establishment of vancomycin-resistant Enterococcus (VRE) stool colonization in mice during treatment, we hypothesized that this agent and other anti-anaerobic antibiotics would increase susceptibility to colonization during the period of recovery of the intestinal microflora.
DESIGN: Mice received 10(4) colony-forming units of vancomycin-resistant E. faecium by orogastric inoculation 2, 5, or 10 days after completing 5 days of subcutaneous antibiotic treatment, or both during and 2 days after the completion of treatment. Denaturing gradient gel electrophoresis (DGGE) was performed to assess changes in the intestinal microflora.
RESULTS: Anti-anaerobic antibiotics (ie, piperacillin/ tazobactam, cefoxitin, and clindamycin) caused significant disruption of the indigenous microflora (mean DGGE similarity indices < or = 27% in comparison with saline controls) and promoted the establishment of high-density colonization when VRE was inoculated 2 or 5, but not 10, days following treatment (P < .001). Piperacillin/tazobactam exhibited a biphasic effect on the establishment of colonization (ie, inhibition when exposed to VRE during treatment and promotion when exposed to VRE after discontinuation of treatment), resulting in greater overall promotion of colonization than did agents with minimal anti-anaerobic activity (ie, levofloxacin, cefepime, and aztreonam) when VRE was inoculated both during and 2 days after treatment (P < .001).
CONCLUSION: Patients receiving anti-anaerobic antibiotics, including piperacillin/tazobactam, may be susceptible to the establishment of high-density VRE colonization during the period of recovery of the anaerobic microflora.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188841     DOI: 10.1086/502408

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  18 in total

1.  The Role of the Intestinal Tract As a Source for Transmission of Nosocomial Pathogens.

Authors:  Usha Stiefel; Curtis J Donskey
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

2.  Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.

Authors:  Nicole J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.

Authors:  Nicole J Pultz; Usha Stiefel; Mahmoud Ghannoum; Marion S Helfand; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

Authors:  Megan K Luther; Louis B Rice; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

Authors:  Mark J DiNubile; Joseph W Chow; Vilas Satishchandran; Adam Polis; Mary R Motyl; Murray A Abramson; Hedy Teppler
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors:  Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

7.  Targeted Metabolomics Analysis Identifies Intestinal Microbiota-Derived Urinary Biomarkers of Colonization Resistance in Antibiotic-Treated Mice.

Authors:  Mark E Obrenovich; MaryAnn Tima; Alex Polinkovsky; Renliang Zhang; Steven N Emancipator; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

8.  Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.

Authors:  David L Paterson; Carlene A Muto; Magdaline Ndirangu; Peter K Linden; Brian A Potoski; Blair Capitano; Robert A Bonomo; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

9.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Authors:  Katharina Brandl; George Plitas; Coralia N Mihu; Carles Ubeda; Ting Jia; Martin Fleisher; Bernd Schnabl; Ronald P DeMatteo; Eric G Pamer
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

10.  Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.

Authors:  Cirle A Warren; Edward van Opstal; T Eric Ballard; Andrew Kennedy; Xia Wang; Mary Riggins; Igor Olekhnovich; Michelle Warthan; Glynis L Kolling; Richard L Guerrant; Timothy L Macdonald; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.